{"database": "lobbying", "table": "lobbying_activities", "rows": [[3488265, "9393c4cf-8d41-4273-a603-4c5bf3a7120a", "Q4", "MARSHALL & POPP, LLC", 401105121, "GENENTECH, INC.", 2025, "fourth_quarter", "CPT", "Issues related to intellectual property and patent reform, including: S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2026-01-16T10:45:24-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3488265"], "units": {}, "query_ms": 94.19044700916857, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}